Stability assay of PASylated proteins in the presence of mouse serum and kidney extracts 10 µg of PAS#1(600)-hGH in PBS was incubated in pooled Balb/C mouse plasma from untreated animals (83 % v/v) at 37 °C for up to 48 h. Samples were taken at different time points, immediately diluted 1:10 with SDS-PAGE running buffer and adjusted with SDS gel loading buffer (5 x concentrated) to 2.5 % v/v 2-mercaptoethanol, followed by heating to 95 °C for 5 min. Then, the samples were subjected to SDS-PAGE (0.33 µg PAS#1(600)-hGH per lane), and a semi-dry Western blot was prepared, followed by detection with a 1:1000 dilution of anti-hGH-HRP conjugate (GhB9-HRP; Abcam, Cambridge, UK).
PASylation p. 2 of the kidney homogenate at varying dilution (1:5, 1:10, 1:100, 1:500, 1:1000) in PBS and incubated at 37 °C for 1 h. Samples were finally diluted 1:10 with SDS-PAGE running buffer, and a Western blot was performed as described above.
Histological analysis of mouse organs after treatment with PAS#1(600)-hGH
After completion of the mouse pharmacodynamic study, two mice from each group treated daily either with the unfused hGH or PAS#1(600)-hGH were subjected to histological analysis of kidney, liver, and spleen (mfd Diagnostics, Wendelsheim, Germany). Animals were sacrificed and the corresponding organs were isolated and stored in 10 % formalin at 4 °C. Paraffin-fixed tissue sections were prepared and stained with haematoxylin/eosin solution. Microscopic analysis was performed using an AXIO Imager A1/M1 (Carl Zeiss, Jena, Germany).
Analysis of mouse sera after PAS#1(600)-hGH treatment for immune reactivity 0.33 µg of different recombinant test proteins, all produced in E. coli and purified as described, were applied to lanes of the same 12 % SDS gel (reduced) and blotted on a nitrocellulose membrane. This Western blot was incubated with a 1:2500 dilution of sera from individual mice of the mouse pharmacodynamic study treated daily either with the unfused hGH or PAS#1(600)-hGH. Bound murine antibodies were detected with a 1:1000 dilution of goat anti-mouse polyvalent Ig/AP conjugate (A0162; Sigma/Aldrich). Therefore, 50 µg protein were mixed with 50 µl 0.9 % w/v NaCl as well as 100 µl complete Freund's adjuvans (Sigma-Aldrich) and injected i.p. Plasma samples were taken after 7, 14, and 21 days.
Mouse immunization and serum analysis by ELISA and Western blotting
On day 21 the immune response was boosted (this time using incomplete Freund's adjuvans in the second immunization experiment with PAS#1(200)-IFN) and additional plasma samples were taken 2 and 7 days thereafter. These samples were analysed by ELISA for the presence of antibodies against the respective immunogen. Briefly, a Maxisorb microtitre plate (NUNC, Roskilde, Denmark) was coated overnight with 50 µl of the corresponding immunogen at a concentration of 25 µg/ml in PBS. After washing, a dilution series of each serum sample was applied and bound murine antibodies were detected with an anti-mouse polyvalent Ig/AP conjugate (A0162; Sigma-Aldrich). In control experiments equivalent membranes were incubated with the anti-mouse polyvalent Ig/AP conjugate only or with a 1:1000 dilution of Strep-Tactin/AP conjugate (IBA, Göttingen, Germany). Finally, the membrane was washed twice with TBS containing 0.05 % v/v Tween-20 and once with citrate-buffered saline (CBS; 10 mM Na-citrate pH 7.0; 137 mM NaCl, 2.7 mM KCl, 0.05 mM MgCl 2 ). For signal development the membrane was incubated with 10 ml After completion of the in vivo PD study, involving administration of PASylated hGH over 10 days (cf. Fig. 5C ), mice were subjected to histochemical analysis of kidney, liver, and spleen.
As an example, typical tissue sections of one mouse are shown. There was no abnormality detected, neither in the mice treated with PAS#1(600)-hGH nor in those receiving the unfused recombinant hGH.
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PASylation p. 14 After completion of the in vivo PD study, involving administration of PASylated hGH over 10 days (cf. Fig. 5C ), mouse sera were probed for immune reactivity. To this end, a set of different test proteins was subjected to Western blotting, followed by incubation with a 1:2500 dilution of sera from individual mice treated either with PAS#1 (600) In both cases, the strongest signals (see arrows) were observed for the unfused IFN and its PASylated versions (lanes 1, 3, and 5). In contrast, much weaker signals appeared for PAS#1 or PAS#5 if fused to the unrelated protein IL-1ra (lanes 2 and 4), indicating low crossreactivity with either PAS sequence alone. In fact, these residual signals can be explained by antibodies directed against the Strep-tag II, which were specifically detected in Fig. S13 . 
